ZA986160B - 2,4,4-trisubstituted-1,3-dioxolone antifungals. - Google Patents

2,4,4-trisubstituted-1,3-dioxolone antifungals.

Info

Publication number
ZA986160B
ZA986160B ZA9806160A ZA986160A ZA986160B ZA 986160 B ZA986160 B ZA 986160B ZA 9806160 A ZA9806160 A ZA 9806160A ZA 986160 A ZA986160 A ZA 986160A ZA 986160 B ZA986160 B ZA 986160B
Authority
ZA
South Africa
Prior art keywords
dioxolone
antifungals
trisubstituted
dioxolone antifungals
Prior art date
Application number
ZA9806160A
Other languages
English (en)
Inventor
Lieven Meerpoel
Jan Heeres
Frank Christopher Odds
Hugo Florent Adolf Van Bossche
Luois Jozef Elisabeth Va Veken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ZA986160B publication Critical patent/ZA986160B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ZA9806160A 1997-07-11 1998-07-10 2,4,4-trisubstituted-1,3-dioxolone antifungals. ZA986160B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97202181 1997-07-11

Publications (1)

Publication Number Publication Date
ZA986160B true ZA986160B (en) 2000-01-10

Family

ID=8228553

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9806160A ZA986160B (en) 1997-07-11 1998-07-10 2,4,4-trisubstituted-1,3-dioxolone antifungals.

Country Status (34)

Country Link
US (1) US6387906B1 (sk)
EP (1) EP1068200B1 (sk)
KR (1) KR100540460B1 (sk)
AP (1) AP1379A (sk)
AR (1) AR015130A1 (sk)
AT (1) ATE289303T1 (sk)
AU (1) AU749760B2 (sk)
BG (1) BG64314B1 (sk)
BR (1) BRPI9811679B8 (sk)
CA (1) CA2295090C (sk)
CZ (1) CZ297453B6 (sk)
DE (1) DE69829082T2 (sk)
DK (1) DK1068200T3 (sk)
EA (1) EA002828B1 (sk)
EE (1) EE04155B1 (sk)
ES (1) ES2238765T3 (sk)
GE (1) GEP20033054B (sk)
HK (1) HK1032404A1 (sk)
HR (1) HRP20000007B1 (sk)
HU (1) HU225159B1 (sk)
ID (1) ID23783A (sk)
IL (1) IL133919A (sk)
MY (1) MY118844A (sk)
NO (1) NO318328B1 (sk)
NZ (1) NZ501982A (sk)
PL (1) PL193703B1 (sk)
PT (1) PT1068200E (sk)
SI (1) SI1068200T1 (sk)
SK (1) SK285321B6 (sk)
TR (1) TR200000154T2 (sk)
TW (1) TW593312B (sk)
UA (1) UA71543C2 (sk)
WO (1) WO1999002523A1 (sk)
ZA (1) ZA986160B (sk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19945982A1 (de) * 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20040086567A1 (en) * 2002-10-30 2004-05-06 Pawan Seth Bioequivalent composition of itraconazole and a hydrophilic polymer
JP2011513398A (ja) * 2008-03-03 2011-04-28 スティーフェル ラボラトリーズ インコーポレイテッド 鏡像異性的に純粋なジオールおよびジオキソラン化合物の製造方法
WO2010099518A2 (en) * 2009-02-27 2010-09-02 Thesis Chemistry, Llc Method for manufacture of 2-oxoimidazolidines
CN105777486B (zh) * 2016-03-30 2018-09-11 浙江大学宁波理工学院 一种2-[2-(2,4-二氟苯基)-2-丙烯-1-基]-1,3-丙二醇的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4619931A (en) 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
US4788190A (en) * 1986-12-24 1988-11-29 Schering Corporation 2,4,4-tri- and 2,2,4,4-tetra substituted-1,3-dioxolane antifungal, antiallergy compounds
NZ233502A (en) 1989-06-09 1991-11-26 Janssen Pharmaceutica Nv 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
IL103558A0 (en) 1991-10-30 1993-03-15 Schering Corp Tri-substituted tetrahydrofuran antifungals
CN1078210C (zh) 1994-01-24 2002-01-23 詹森药业有限公司 水溶性吡咯系杀真菌剂

Also Published As

Publication number Publication date
EP1068200A1 (en) 2001-01-17
EA002828B1 (ru) 2002-10-31
IL133919A (en) 2002-02-10
UA71543C2 (uk) 2004-12-15
KR100540460B1 (ko) 2006-01-12
NO20000114L (no) 2000-03-13
AU8857698A (en) 1999-02-08
AR015130A1 (es) 2001-04-18
AP2000001730A0 (en) 2000-03-31
KR20010020576A (ko) 2001-03-15
HU225159B1 (en) 2006-07-28
HK1032404A1 (en) 2001-07-20
CA2295090A1 (en) 1999-01-21
AP1379A (en) 2005-03-29
ES2238765T3 (es) 2005-09-01
EP1068200B1 (en) 2005-02-16
NO318328B1 (no) 2005-03-07
BG64314B1 (bg) 2004-09-30
CA2295090C (en) 2009-09-08
ID23783A (id) 2000-05-11
BR9811679A (pt) 2000-09-19
EA200000116A1 (ru) 2000-08-28
DE69829082T2 (de) 2005-12-29
SK184199A3 (en) 2000-07-11
BRPI9811679B8 (pt) 2021-05-25
HRP20000007A2 (en) 2000-12-31
PL193703B1 (pl) 2007-03-30
CZ297453B6 (cs) 2006-12-13
HRP20000007B1 (en) 2008-12-31
BG103982A (en) 2000-08-31
TR200000154T2 (tr) 2000-06-21
TW593312B (en) 2004-06-21
ATE289303T1 (de) 2005-03-15
BRPI9811679B1 (pt) 2016-10-18
CZ463799A3 (cs) 2000-04-12
EE04155B1 (et) 2003-10-15
PL338009A1 (en) 2000-09-25
IL133919A0 (en) 2001-04-30
MY118844A (en) 2005-01-31
US6387906B1 (en) 2002-05-14
GEP20033054B (en) 2003-08-25
HUP0004459A2 (hu) 2002-04-29
DE69829082D1 (de) 2005-03-24
NO20000114D0 (no) 2000-01-10
SK285321B6 (sk) 2006-11-03
WO1999002523A1 (en) 1999-01-21
SI1068200T1 (sk) 2005-08-31
PT1068200E (pt) 2005-07-29
NZ501982A (en) 2000-10-27
HUP0004459A3 (en) 2002-11-28
DK1068200T3 (da) 2005-06-20
EE200000020A (et) 2000-10-16
AU749760B2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
ZA9710429B (en) Broad-spectrumδ-endotoxins.
HK1016976A1 (en) Resorcinyl-triazine.
ZA985875B (en) Azetidines.
ZA981926B (en) Detergent--package combination.
ZA973984B (en) 2,4-diaminopyrimidine derivatives.
ZA987055B (en) Substituted 4-benzoylpyrazoles.
DE59804842D1 (en) Aliphatische, emissionsarme, sinterfähige thermoplastische polyurethanformmassen
ZA987058B (en) Substituted 4-benzoylpyrazoles.
HK1017834A1 (en) Bodyshaper.
ZA9811070B (en) Type I interferons.
GB2331075B (en) I.S. machine
ZA983705B (en) Pregnan-3-ol-20-ones.
ZA986160B (en) 2,4,4-trisubstituted-1,3-dioxolone antifungals.
GB2331081B (en) I.S. Machine
GB2331096B (en) I.S.machine
ZA987B (en) Substituted 4-benzoylpyrazoles.
GB2331082B (en) I.s Machine
GB2331095B (en) I.s. machine
GB2331092B (en) I.s. machine
ZA971466B (en) Endothelin-receptor-antagonists.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.
ZA984592B (en) Herbicidal 3,5-difluoropyridines.
GB2331084B (en) I.s. Machine
ZA981309B (en) 4-aminoalkoxy-1H-benzoimidazoles.
ZA983795B (en) Substituted 4-benzoyl-pyrazoles.